Multiple Sclerosis Current Events | Multiple Sclerosis News | 8
|
| Page
8 of
23 |
444 Results |
|
|
|
Sort By:
Page Views | Date |
“Shooting the messenger” to tackle autoimmune diseases
AIDS and other autoimmune diseases could be tackled with a range of new drugs that stop cells recognising certain chemical messages in blood, says Dr Gerry Graham from the Glasgow-based Institute for Cancer Research speaking at the BA Festival of Science today [3 September 2001]. Autoimmune diseases, including rheumatoid arthritis, multiple... view more... (2001-08-30)
Stem cells as cancer therapy
It is widely hoped that neural stem cells will eventually be useful for replacing nerves damaged by degenerative diseases like Alzheimer disease and multiple sclerosis. But there may also be another use for such stem cells-delivering anti-cancer drugs to cancer cells. view more (2006-12-26)
New role for sugars: Research shows connections between sugar modifications in cells and cancer
In a ground-breaking study published in the top journal, Cell, Dr. James Dennis, senior investigator at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, has discovered a new role for sugars on proteins. view more (2007-04-06)
Smoking marijuana impairs cognitive function in MS patients
People with multiple sclerosis (MS) who smoke marijuana are more likely to have emotional and memory problems. view more (2008-02-14)
High polyunsaturated fat and vitamin E intake may halve motor neurone disease risk
A high dietary intake of polyunsaturated fat and vitamin E seems to halve the risk of developing motor neurone disease, suggests research published ahead of print in the Journal of Neurology Neurosurgery and Psychiatry. view more (2006-04-27)
Response to immune protein determines pathology of multiple sclerosis
New research may help reveal why different parts of the brain can come under attack in patients with multiple sclerosis (MS). According to a new study in mice with an MS-like disease, the brain's response to a protein produced by invading T cells dictates whether it's the spinal cord or cerebellum that comes under fire. view more (2008-10-14)
After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis
A pair of large-scale genetic studies supported by the National Institutes of Health has revealed two genes that influence the risk of getting multiple sclerosis (MS) - data sought since the discovery of the only other known MS susceptibility gene decades ago. view more (2007-07-30)
Family members with MS likely to share onset age, but not disease severity
When more than one member of a family is affected by multiple sclerosis (MS), their ages at disease onset are likely to be similar, but disease severity may not be. view more (2007-01-30)
UK research unveils new generation of immunological adjuvants
Investment from the White Rose Technology Seedcorn Fund (WRTSF) - the venture capital fund owned by the universities of Leeds, Sheffield and York (UK) - has funded the completion of a series of significant technical milestones in the development of a new family of `immunologically-rational` adjuvants for vaccines, which are materially very... view more... (2002-08-13)
LSUHSC's England plays key role in developing new ALS treatment guidelines
Dr. John England, Professor and Chairman of Neurology at LSU Health Sciences Center New Orleans, analyzed research findings and was responsible for the quality and accuracy of evidence analysis and the conclusions of the studies resulting in new guidelines for treating Lou Gehrig's disease, or amyotropic lateral sclerosis (ALS). view more (2009-10-13)
THE LANCET Neurology PRESS RELEASE
ISSUE: AUGUST 2002 FOR IMMEDIATE RELEASE view more (2002-07-17)
Research teams uncover risk genes for multiple sclerosis
Two new large-scale genomic studies have honed in on the main genetic pathway associated with multiple sclerosis (MS), while also uncovering new genetic variations in the disease and suggesting a possible link between MS and other autoimmune diseases. view more (2007-07-31)
Experimental MS drug shows promise, offers new window on disease
A drug therapy currently used to treat non-Hodgkin's lymphoma and rheumatoid arthritis had a significant effect in treating the most common form of multiple sclerosis in a small, short-term clinical trial. view more (2008-02-14)
Why do some queen bees eat their worker bee's eggs?
Worker bees, wasps, and ants are often considered neuter. But in many species they are females with ovaries, who although unable to mate, can lay unfertilized eggs which turn into males if reared. view more (2006-12-05)
Protective action of a molecule in inflammatory processes discovered
Henar Hevia Pérez, researcher in the area of Genic Therapy and Hepatology at the Applied Medicine Research Centre (CIMA)of the University of Navarra, has discovered the protective role of the methylthioadenosine (MTA) molecule in an in vivo inflammation model. view more (2006-04-27)
High-dose Interferon Beta-1B On Alternate Days Could Offer Increased Clinical Benefit For People With Multiple Sclerosis (p 1453)
A study published in this week's issue of THE LANCET suggests that high-dose interferon beta-1b administered every other day is more effective than interferon beta-1a once a week for people with multiple sclerosis (MS). There are three interferon beta therapies known to be effective in reducing MS symptoms: interferon beta-1a 30 mcg administered... view more... (2002-04-24)
Hormone irregularities linked to chronic migraine
Hormonal irregularities may explain why migraine becomes chronic, shows research in the Journal of Neurology Neurosurgery and Psychiatry. Around 3 per cent of the population are chronic migraineurs, suffering pounding headaches for around 15 days a month. Hourly blood samples were taken from 17 chronic migraine sufferers, three of whom were men.... view more... (2001-11-23)
Harvard scientists identify compounds that stimulate stem cell growth in the brain
cientists at Harvard University have identified key compounds that stimulate stem cell growth in the brain, which may one day lead to restored function for people affected by Parkinson's disease, strokes, multiple sclerosis, and a wide range of neurological disorders. view more (2006-09-01)
In the war against diseases, nerve cells need their armor
In a new study, researchers at the Montreal Neurological Institute (MNI), McGill University, and the Université de Montréal have discovered an essential mechanism for the maintenance of the normal structure of myelin, the protective covering that insulates and supports nerve cells (neurons). view more (2008-11-13)
UM scientists pinpoint critical molecule to celiac disease, possibly other autoimmune disorders
It was nine years ago that University of Maryland School of Medicine researchers discovered that a mysterious human protein called zonulin played a critical role in celiac disease and other autoimmune disorders, such as multiple sclerosis and diabetes. view more (2009-09-08)
|
|
| Page
8 of
23 |
444 Results |
|
|
|
Sort By:
Page Views | Date |
|
